CVS Caremark has inked a three-year agreement with ActiveHealth Management, an independent subsidiary of Aetna, under which CVS Caremark will apply the evidence-based, clinical intelligence of the ActiveHealth CareEngine to healthcare claims for its PBM customers to identify opportunities for improved pharmacy care.

A group of drug makers have sued Mylan over its attempt to gain Food and Drug Administration approval for a generic menopause drug, Mylan said Tuesday.

The Food and Drug Administration has taken action against makers of prescription drugs for cough-cold and allergies that don’t have regulatory approval, the agency said Wednesday.

Want to be a rock star, or at least look like one? Check out Göt2b Rockin' It.

Kmart is continuing its support of the March of Dimes by collaborating with the organization for the 28th time.

Health-and-wellness retailer Max-Wellness on Tuesday announced a series of initiatives that vastly will expand the reach of the upstart company.

Following the warning letter it received last April, Perrigo announced that the Food and Drug Administration has arrived at the company's Allegan, Mich.-based facility for re-inspection.

The Food and Drug Administration is warning that long-term use of a class of drugs for gastroesophageal reflux disease may decrease levels of magnesium in the body and increase the risk of such side effects as seizures and heart rhythm problems, according to published reports.

Apna International has launched at Target a new fragrance collection called Tattooed By Inky, which features fragrances for both men and women.

Walgreens has won recognition from a company that designs medication therapy management programs.

Walgreens said its pharmacies are prepared to compound Tamiflu capsules into liquid form as the Centers for Disease Control and Prevention reported widespread flu activity in the United States.

Three years after purchasing a minority stake in Honest Tea, an organic bottled tea company, Coca-Cola said it has exercised its option to acquire the remaining portion of the company.